Skip to main content
Log in

Prevalence of human papilloma virus infection in women in rural Ethiopia

  • Letter to the Editor
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

In Ethiopia cervical carcinoma is the most frequent cancer in women. HPV infection is a prerequisite for this disease. However, to date there have been no data on human papilloma virus (HPV) prevalence in Ethiopia. Outpatients attending Attat hospital in rural Ethiopia were examined for the presence of HPV DNA using the Digene HPV test. 15.9% of patients were found to be HPV positive. The proportion of HPV high risk types was 13.2% [age-standardised rates: HPV: 14.4% (95% CI: 8.5–20.2); HPV high risk: 11.6% (95% CI: 6.3–16.9)]. Compared to other countries HPV prevalence is high, especially of high risk types. Until vaccination programmes take effect, screening programmes should not be based on HPV testing alone as this will lead to significant overtreatment of healthy women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. GEKID (2006) Krebs in Deutschland. Häufigkeiten und Trends. Saarbrücken: GEKID, Robert Koch Institut

    Google Scholar 

  2. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. (2006) HPV-mediated cervical carcinogenesis: Concepts and clinical implications J Pathol 208(2):152–164

    Article  PubMed  CAS  Google Scholar 

  3. Munoz N, Bosch FX, de Sanjose S, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527

    Article  PubMed  Google Scholar 

  4. Schiffman M, Castle PE. (2005) The promise of global cervical-cancer prevention N Engl J Med 353(20):2101–2104

    Article  PubMed  CAS  Google Scholar 

  5. Clifford GM, Gallus S, Herrero R, et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis Lancet 366(9490):991–998

    Article  PubMed  CAS  Google Scholar 

  6. Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A. (2001) Detection of high-risk HPV types by the hybrid capture 2 test J Med Virol 65(1):155–162

    Article  PubMed  CAS  Google Scholar 

  7. Doll R, Payne P, Waterhouse JBS-Vf, UICC. Cancer Incidence in Five Continents: A Technical Report. Berlin: Springer Verlag, 1966

  8. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. (2005) Cost-effectiveness of cervical-cancer screening in five developing countries N Engl J Med 353(20):2158–2168

    Article  PubMed  CAS  Google Scholar 

  9. Kelly J, Fekadu S, Lancashire RJ, Poovan P, Redito A. (1998) A follow-up of repair of ruptured uterus in Ethiopia J Obstet Gynaecol 18(1):50–52

    Article  PubMed  CAS  Google Scholar 

  10. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr (2000) Evaluation of alternative methods of cervical cancer screening for resource-poor settings Cancer 89(4):826–833

    Article  PubMed  CAS  Google Scholar 

  11. El-Shalakany A, Hassan SS, Ammar E, Ibrahim MA, Salam MA, Farid M. (2004) Direct visual inspection of the cervix for the detection of premalignant lesions J Low Genit Tract Dis 8(1):16–20

    Article  PubMed  Google Scholar 

  12. Basu PS, Sankaranarayanan R, Mandal R, et al. (2003) Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India Int J Gynecol Cancer 13(5):626–632

    Article  PubMed  CAS  Google Scholar 

  13. Harper DM, Franco EL, Wheeler C, et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial Lancet 364(9447):1757–1765

    Article  PubMed  CAS  Google Scholar 

  14. Villa LL, Costa RL, Petta CA, et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6(5):271–278

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

To Hartmut Götte PhD, Digene Corp., Germany, for HPV diagnostic test kits, Birgit Konert and Magdalena Marciniak for expert technical assistance, and Jürgen Wellmann for statistical advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. J. Lellé.

Additional information

Sr. Rita Schiffer, M.D., Member of the Medical Mission Sisters and Medical Director, Attat Hospital.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruland, R., Prugger, C., Schiffer, R. et al. Prevalence of human papilloma virus infection in women in rural Ethiopia. Eur J Epidemiol 21, 727–729 (2006). https://doi.org/10.1007/s10654-006-9055-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-006-9055-4

Keywords

Navigation